Anterogen Co (XKRX:065660) COGS-to-Revenue : 0.63 (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co COGS-to-Revenue?

Anterogen Co's Cost of Goods Sold for the three months ended in Sep. 2024 was ₩1,197 Mil. Its Revenue for the three months ended in Sep. 2024 was ₩1,903 Mil.

Anterogen Co's COGS to Revenue for the three months ended in Sep. 2024 was 0.63.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Anterogen Co's Gross Margin % for the three months ended in Sep. 2024 was 37.07%.

Anterogen Co COGS-to-Revenue Historical Data

The historical data trend for Anterogen Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co COGS-to-Revenue Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.60

0.58

0.52

0.60

0.59

Anterogen Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.55	0.51	0.61	0.62	0.63

Anterogen Co COGS-to-Revenue Calculation

Anterogen Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3833.896	/	6500.25
	=	0.59

Anterogen Co's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1197.378	/	1902.592
	=	0.63

Anterogen Co (XKRX:065660) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Anterogen Co's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1197.378 / 1902.592
	=	37.07 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Anterogen Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Anterogen Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co Headlines

No Headlines